Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04101331Phase 2Completed
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
Peripheral T Cell LymphomaTransformed Mycosis Fungoides
StudydirectorStart date: 2019-11-13

Research Network

Collaboration Network

18 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Affimed Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Won Seog Kim, Dr

Samsung Medical Center

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralTransformed Mycosis Fungoides

Worked with same sponsors:

Affimed GmbH
Collaborated on 1 trial
Similarity Score24%

Steven Horwitz, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralTransformed Mycosis Fungoides

Worked with same sponsors:

Affimed GmbH
Collaborated on 1 trial
Similarity Score24%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Eliot Epner, MD

Penn State Hershey Cancer Institute

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Maria Delioukina, MD

City of Hope National Medical Center, USA

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Peter Brown, MD

H:S Rigshospitalet, Department of Hematology, Denmark

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Madeleine Duvic, MD

UT - M. D. Anderson Cancer Center

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Fernando Camacho, MD

Bronx River Medical Associates, PC

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Andrei Shustov, MD

Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Andreas Neubauer, MD

University Hospital Marburg, Marburg, Germany

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04101331Phase 2StudyDirector

Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

Peripheral T Cell LymphomaTransformed Mycosis Fungoides
Completed

All 1 trials loaded